Serum lectin with known structure activates complement through the classical pathway.

PubWeight™: 2.79‹?› | Rank: Top 1%

🔗 View Article (PMID 3584121)

Published in J Biol Chem on June 05, 1987

Authors

K Ikeda, T Sannoh, N Kawasaki, T Kawasaki, I Yamashina

Articles citing this

The human mannose-binding protein functions as an opsonin. J Exp Med (1989) 3.15

Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med (1992) 2.76

Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun (2000) 2.71

Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29

A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med (1988) 2.24

The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest (2002) 2.13

Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med (2004) 2.12

The Mac-2 antigen is a galactose-specific lectin that binds IgE. J Exp Med (1989) 1.98

Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol (2000) 1.86

The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med (1989) 1.64

Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med (2000) 1.56

Paths reunited: Initiation of the classical and lectin pathways of complement activation. Immunobiology (2009) 1.50

Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest (1989) 1.47

The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol (1990) 1.37

Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease. Biochem J (1996) 1.30

Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J (1989) 1.29

A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27

Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J (1994) 1.26

Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochem J (1989) 1.20

Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci U S A (2012) 1.17

Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol (2005) 1.17

Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect Immun (1996) 1.16

Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. Proc Natl Acad Sci U S A (1992) 1.14

Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09

Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1999) 1.09

Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08

Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum. Clin Exp Immunol (1997) 1.03

Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun (2003) 1.01

Asymmetry adjacent to the collagen-like domain in rat liver mannose-binding protein. Biochem J (1997) 1.00

Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology (1994) 0.99

Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun (1993) 0.97

Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin Exp Immunol (1998) 0.96

Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin Diagn Lab Immunol (1998) 0.96

Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect Immun (2005) 0.95

Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant. Infect Immun (2007) 0.93

Comparative study of the structural and functional properties of a bovine plasma C-type lectin, collectin-43, with other collectins. Biochem J (1995) 0.92

The role of humoral innate immunity in hepatitis C virus infection. Viruses (2012) 0.91

Conformation of a trimannoside bound to mannose-binding protein by nuclear magnetic resonance and molecular dynamics simulations. Biophys J (2002) 0.90

The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol (1995) 0.90

Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice. J Invest Dermatol (2007) 0.89

Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi. Proc Natl Acad Sci U S A (1997) 0.89

Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci (2005) 0.89

Purification and characterization of the core-specific lectin from human serum and liver. Biochem J (1988) 0.89

Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins. Clin Exp Immunol (1999) 0.89

An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet (2005) 0.88

Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology (1995) 0.87

Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun (1998) 0.86

Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect Immun (1997) 0.85

Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus. Biochem J (1996) 0.85

The lectin pathway of complement and rheumatic heart disease. Front Pediatr (2015) 0.84

The Gly-54-->Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J (1995) 0.84

A study of novel lectins and their involvement in the activation of the prophenoloxidase system in Blaberus discoidalis. Biochem J (1995) 0.84

Collectins, collectin receptors and the lectin pathway of complement activation. Clin Exp Immunol (1994) 0.83

Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP). Mol Immunol (2009) 0.83

Cloning and sequencing of a cDNA encoding chicken mannan-binding lectin (MBL) and comparison with mammalian analogues. Immunology (1998) 0.83

Detection, isolation and characterization of multiple lectins from the haemolymph of the cockroach Blaberus discoidalis. Biochem J (1993) 0.83

Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis. Infect Immun (2004) 0.82

Genetic polymorphisms of mannose-binding lectin do not influence placental malaria but are associated with preterm deliveries. Infect Immun (2009) 0.82

Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.81

Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP). Glycoconj J (2004) 0.81

The x-ray crystal structure of mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome. J Biol Chem (2013) 0.81

Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*. Immunology (1999) 0.81

Serum levels, ontogeny and heritability of chicken mannan-binding lectin (MBL). Immunology (1998) 0.80

Depressed activation of the lectin pathway of complement in hereditary angioedema. Clin Exp Immunol (2008) 0.79

Mannan-binding lectin of the sea urchin Strongylocentrotus nudus. Mar Biotechnol (NY) (2012) 0.79

Genetic Susceptibility to Sepsis: A Possible Role for Mannose-binding Lectin. Curr Infect Dis Rep (2004) 0.79

The Expression Analysis of Complement Component C3 during Early Developmental Stages in Olive Flounder (Paralichthys olivaceus). Balsaenggwa Saengsig (2013) 0.76

Serum mannan-binding lectin in egyptian patients with chronic hepatitis C: its relation to disease progression and response to treatment. Hepat Mon (2012) 0.75

Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections. World J Hepatol (2010) 0.75

Toll-like receptors (TLRs) and mannan-binding lectin (MBL): on constant alert in a hostile environment. Ups J Med Sci (2011) 0.75

Detection and characterization of natural and inducible lectins in human serum. Results Immunol (2012) 0.75

Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis. Glycoconj J (1998) 0.75

Articles by these authors

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97

[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06

Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature (1998) 4.68

Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev (2000) 4.38

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res (1991) 4.31

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum (2008) 4.25

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17

Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut (2008) 4.07

Disappearance and reformation of synaptic vesicle membrane upon transmitter release observed under reversible blockage of membrane retrieval. J Neurosci (1989) 3.78

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut (2006) 3.59

Reversible blockage of membrane retrieval and endocytosis in the garland cell of the temperature-sensitive mutant of Drosophila melanogaster, shibirets1. J Cell Biol (1983) 3.44

Possible temperature-dependent blockage of synaptic vesicle recycling induced by a single gene mutation in Drosophila. J Neurobiol (1983) 3.36

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02

Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol (1985) 2.72

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology (1998) 2.67

Essential role of the small GTPase Rac in disease resistance of rice. Proc Natl Acad Sci U S A (2001) 2.45

NAK is an IkappaB kinase-activating kinase. Nature (2000) 2.44

Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42

Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol (2012) 2.34

Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice. Cell (1995) 2.25

Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25

Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. J Biol Chem (1991) 2.23

Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1988) 2.20

Feasibility of stomach exploration with a guided capsule endoscope. Endoscopy (2010) 2.20

Isolation and characterization of an avian hepatic binding protein specific for N-acetylglucosamine-terminated glycoproteins. J Biol Chem (1977) 2.18

Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18

Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet (2000) 2.17

Synaptic vesicles have two distinct recycling pathways. J Cell Biol (1996) 2.17

The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15

Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation (1989) 2.14

The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem (1998) 2.07

The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05

Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun (1978) 2.04

Six family genes--structure and function as transcription factors and their roles in development. Bioessays (2000) 2.03

Airway management of a child with temporomandibular joint ankylosis following otitis media. Anaesthesia (2002) 2.01

Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A (1986) 1.99

Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer (2000) 1.98

Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science (1994) 1.98

Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97

Patterned neural activity of a mutant Drosophila melanogaster. Proc Natl Acad Sci U S A (1970) 1.97

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology (1994) 1.96

Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95

Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc' Working Group. Hypertension (1997) 1.90

DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89

Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut (2004) 1.89

Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme. J Biol Chem (1987) 1.87

Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics (2001) 1.85

Isolation and characterization of a mannan-binding protein from human serum. J Biochem (1983) 1.83

Kawasaki disease in families. Pediatrics (1989) 1.83

Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med (1988) 1.82

Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med (1991) 1.80

Synaptic transmission reversibly conditioned by single-gene mutation in Drosophila melanogaster. Nature (1976) 1.79

Flexible endoneurosurgical therapy for aqueductal stenosis. Neurosurgery (1993) 1.77

Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody. J Nucl Med (1998) 1.76

Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol (1999) 1.75

Enzymatic cleavage of glycopeptides. Biochem Biophys Res Commun (1966) 1.73

Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma. Cancer (2000) 1.73

Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins. J Biol Chem (1976) 1.73

CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol (1995) 1.72

Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. Mol Cell Biol (2000) 1.72

Alteration of the structural properties of starch components by the lack of an isoform of starch branching enzyme in rice seeds. J Biol Chem (1993) 1.71

Relation between initial blood distribution volume and propofol induction dose requirement. Anesthesiology (2001) 1.68

Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene (1999) 1.68

Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat Neurosci (1999) 1.66

Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry (1981) 1.66

Genetic mapping with a thiamine-requiring auxotroph of Escherichia coli K-12 defective in thiamine phosphate pyrophosphorylase. J Bacteriol (1968) 1.66

Purification and characterization of a novel GTP-binding protein with a molecular weight of 24,000 from bovine brain membranes. J Biol Chem (1988) 1.66

Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology (1997) 1.66

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology (1997) 1.65

Congenital primitive neuroectodermal tumor with epithelial and glial differentiation. An ultrastructural and immunohistochemical study. Arch Pathol Lab Med (1990) 1.65

G-language Genome Analysis Environment: a workbench for nucleotide sequence data mining. Bioinformatics (2003) 1.64

Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol (1998) 1.61

Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients. Lancet (1992) 1.61

Diagnosis and treatment of Hirschsprung's disease in Japan. An analysis of 1628 patients. Ann Surg (1984) 1.61

Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med (1998) 1.61

Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J (2002) 1.60

Transformational process of the endosomal compartment in nephrocytes of Drosophila melanogaster. Cell Tissue Res (1990) 1.59

A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis (1988) 1.57

The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology (1998) 1.56

Electroencephalographic derivatives as a tool for predicting the depth of sedation and anesthesia induced by sevoflurane. Anesthesiology (1998) 1.55

Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem (2001) 1.55

Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett (1996) 1.53

In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives. Eur J Biochem (2000) 1.53

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol (1994) 1.52

Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology (2001) 1.52

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol (2008) 1.52

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med (1998) 1.51

Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane, and isoflurane. J Clin Anesth (1991) 1.51

Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy (2009) 1.51

Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia. Am J Gastroenterol (1995) 1.50

Prevalence of TT virus before and after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma. J Gastroenterol Hepatol (1999) 1.50

A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem (1989) 1.50

The nucleotide sequence of cDNA for a Drosophila ribosomal protein with homology to rat ribosomal protein S26. Nucleic Acids Res (1989) 1.48

A craniocervical injury-induced syringomyelia caused by central canal dilation secondary to acquired tonsillar herniation. Case report. J Neurosurg (2001) 1.48

The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer (1997) 1.48